These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37479968)

  • 21. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
    Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
    PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran.
    Fesharakinia A; Zarban A; Sharifzadeh GR
    Arch Iran Med; 2008 Nov; 11(6):598-601. PubMed ID: 18976028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
    Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
    Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan.
    Abdel-Aal NM; Ahmad AT; Froelicher ES; Batieha AM; Hamza MM; Ajlouni KM
    Saudi Med J; 2008 Oct; 29(10):1423-8. PubMed ID: 18946566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and Prevalence of Dyslipidemia Among Adult Population of Tehran: The Tehran Cohort Study.
    Shafiee A; Kazemian S; Jalali A; Alaeddini F; Saadat S; Masoudkabir F; Tavolinejad H; Vasheghani-Farahani A; Arita VA; Sadeghian S; Boroumand M; Karimi A; Franco OH
    Arch Iran Med; 2024 Feb; 27(2):51-61. PubMed ID: 38619028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Threshold-Effect Association of Dietary Cholesterol Intake with Dyslipidemia in Chinese Adults: Results from the China Health and Nutrition Survey in 2015.
    Huang Q; Jiang H; Zhang B; Wang H; Jia X; Huang F; Wang L; Wang Z
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
    Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
    J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.
    Abera A; Worede A; Hirigo AT; Alemayehu R; Ambachew S
    Eur J Med Res; 2024 Apr; 29(1):237. PubMed ID: 38622622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria.
    Bello-Ovosi BO; Ovosi JO; Ogunsina MA; Asuke S; Ibrahim MS
    Pan Afr Med J; 2019; 34():123. PubMed ID: 33708292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia.
    Addisu B; Bekele S; Wube TB; Hirigo AT; Cheneke W
    BMC Cardiovasc Disord; 2023 Jun; 23(1):321. PubMed ID: 37355585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of dyslipidemia and its influential factors in 2 028 students from primary and middle schools in Changsha].
    Li Y; Luo J; Ma J; Zou Z; Liu X; Li H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):673-680. PubMed ID: 28690226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province.
    Pongchaiyakul C; Pongchaiyakul C; Pratipanawatr T
    J Med Assoc Thai; 2005 Aug; 88(8):1092-7. PubMed ID: 16404837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence trends and related factors of hypertension patients complicating with dyslipidemia in community of Guandong province between 2013 and 2018].
    Huang YQ; Li J; Chen JY; Feng YQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):986-992. PubMed ID: 34674436
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China.
    Yu S; Yang H; Guo X; Zhang X; Zheng L; Sun Y
    BMC Public Health; 2015 Nov; 15():1152. PubMed ID: 26589291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.